Home> Products> monitor

{ "products": [ { "_id": "6a8c3838c90065ecdc86c757", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Semaglutide Injection 4mg", "description": "SAMIGLUTIDE 4 MG is a semaglutide-containing injectable medicine supplied in a pre-filled pen. The stated formulation contains 4 mg of semaglutide in 3 mL of solution, corresponding to approximately 1.34 mg/mL.\n\nSemaglutide is a GLP-1 receptor agonist that acts on physiological pathways involved in blood-glucose control, appetite, and gastrointestinal function. Its use should be based on the approved indication for the specific product and the advice of a qualified healthcare professional.\n\nProduct Overview\nProduct: SAMIGLUTIDE 4 MG\nActive substance: Semaglutide\nStrength: 4 mg/3 mL\nApproximate concentration: 1.34 mg/mL\nDosage form: Injectable solution\nPresentation: Pre-filled pen\nRoute: Subcutaneous administration, according to the applicable product instructions\n\nThe 4 mg/3 mL concentration is also associated with certain approved semaglutide products. However, this does not mean that their dosing schedules, indications, or administration instructions automatically apply to SAMIGLUTIDE 4 MG. The product-specific labeling should always be followed.\n\nWhat Is Semaglutide?\n\nSemaglutide is a medication belonging to the GLP-1 receptor agonist class. It acts similarly to the naturally occurring hormone glucagon-like peptide-1 (GLP-1).\n\nGLP-1 is involved in several processes related to metabolism. Its activity can influence insulin secretion, glucagon regulation, stomach emptying, and appetite. Depending on the particular semaglutide product and its regulatory authorization, semaglutide may be prescribed for conditions such as type 2 diabetes or chronic weight management in appropriately selected patients.\n\nBecause different semaglutide products can have different approved uses and formulations, treatment decisions should be based on the specific medicine being prescribed.\n\nSAMIGLUTIDE 4 MG Pre-Filled Pen\n\nSAMIGLUTIDE 4 MG is supplied in a pre-filled pen intended to provide a convenient format for subcutaneous administration.\n\nPre-filled devices can eliminate the need to draw medication from a conventional vial. Nevertheless, patients should be properly trained before using an injectable pen and should follow the instructions supplied with the specific product.\n\nThe pen should only be used according to its approved instructions, including the prescribed dose and administration schedule.\n\nStrength and Formulation\n\nEach stated 3 mL presentation contains 4 mg of semaglutide, giving a concentration of approximately 1.34 mg/mL.\n\nThe concentration of a medicine should not be confused with the amount delivered in every injection. The quantity administered depends on the design and dose settings of the particular pen.\n\nFor this reason, patients should not calculate or select their own dose based solely on the concentration printed on the package. The prescribed dose should come from the product's authorized instructions and the treating healthcare professional.\n\nHow Semaglutide Acts\n\nSemaglutide activates GLP-1 receptors, which are involved in the regulation of blood glucose and appetite.\n\nAmong its physiological effects, GLP-1 receptor activation can:\n\nSupport glucose-dependent insulin secretion.\nReduce inappropriate glucagon secretion when blood glucose is elevated.\nAffect gastrointestinal activity, including gastric emptying.\nInfluence appetite and food intake.\n\nThe overall response to treatment can vary between individuals and depends on factors such as the medical indication, prescribed dose, treatment duration, and other medicines being used.\n\nPotential Therapeutic Benefits\n\nWhen prescribed for an appropriate, authorized indication, semaglutide may form part of a broader treatment program.\n\nFor eligible individuals with type 2 diabetes, certain approved semaglutide medicines are used to improve glycemic control. Other approved semaglutide formulations have indications involving chronic weight management for qualifying patients.\n\nMedication should be considered alongside the broader treatment strategy recommended by a healthcare professional, which may include nutritional management, physical activity, glucose monitoring, and other appropriate interventions.\n\nPossible Side Effects\n\nLike other prescription medicines, semaglutide can cause unwanted effects.\n\nFrequently reported gastrointestinal reactions associated with semaglutide products include:\n\nNausea\nVomiting\nDiarrhea\nConstipation\nAbdominal discomfort or pain\n\nNot every patient experiences these effects, and their severity can vary.\n\nSemaglutide products also have important safety considerations. Depending on the specific approved product, labeling includes warnings concerning conditions such as pancreatitis, gallbladder-related problems, severe gastrointestinal reactions, kidney problems associated with dehydration, and serious hypersensitivity reactions.\n\nPatients should provide their healthcare professional with a complete medical history before treatment begins.\n\nImportant Contraindications and Warnings\n\nCertain semaglutide products carry a contraindication for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Serious hypersensitivity to semaglutide or an applicable component is also an important contraindication.\n\nThe exact warnings and contraindications applicable to SAMIGLUTIDE 4 MG should be confirmed against its current authorized product information in the relevant country.\n\nPatients should seek professional medical advice if they develop concerning symptoms during treatment.\n\nCorrect Administration\n\nSAMIGLUTIDE 4 MG should be administered only according to the prescription and instructions applicable to the product.\n\nBefore using a pre-filled pen, patients should receive appropriate instruction regarding:\n\nDose selection\nInjection technique\nInjection sites\nPen operation\nStorage\nDisposal of used needles or injection equipment\n\nThe dose or frequency should never be changed independently.\n\nA pre-filled injection pen should not be shared with another person, even if a new needle is attached. Sharing injectable medication devices can create a risk of transmitting infections and is contrary to appropriate safe-use practices.\n\nStorage\n\nStorage requirements should be determined from the official SAMIGLUTIDE 4 MG packaging and product information supplied with the medicine.\n\nPatients should not rely on storage instructions from a different semaglutide brand because formulations, devices, and stability requirements can differ between products.\n\nUse by Healthcare Professionals\n\nHealthcare professionals should assess whether SAMIGLUTIDE 4 MG is appropriate for an individual patient by considering the relevant diagnosis, treatment objectives, medical history, contraindications, concurrent medicines, and applicable regulatory requirements.\n\nParticular attention should be given to the distinction between different semaglutide products. Although they contain the same active ingredient, products may differ in:\n\nApproved indications\nConcentration\nPen design\nDose increments\nAdministration schedules\nStorage conditions\nRegulatory labeling\n\nThe product-specific prescribing information should therefore be consulted before treatment is initiated or adjusted.\n\nAdvantages of a Pre-Filled Pen\n\nA pre-filled pen can provide a practical method of administering an injectable medicine. Compared with a conventional vial-and-syringe presentation, the device may reduce some preparation steps and can be convenient for patients who have been appropriately trained.\n\nConvenience, however, should not take precedence over product authenticity, regulatory approval, correct dosing, proper storage, and professional medical supervision.\n\nSAMIGLUTIDE 4 MG: Key Points\n\nSAMIGLUTIDE 4 MG is described as a semaglutide injection containing 4 mg in 3 mL, supplied in a pre-filled pen.\n\nThe most important considerations are:\n\nSemaglutide is a GLP-1 receptor agonist.\nThe stated formulation is 4 mg/3 mL (approximately 1.34 mg/mL).\nAdministration is by the subcutaneous route when prescribed for that route.\nThe appropriate dose and frequency must come from the product-specific instructions and prescription.\nDosing information from another semaglutide brand should not automatically be applied.\nPatients should be informed about possible adverse reactions and relevant contraindications.\nThe pen must not be shared between patients.\nStorage and handling should follow the official product information.\nTreatment should be supervised by an appropriately qualified healthcare professional.\nFrequently Asked Questions\nWhat is SAMIGLUTIDE 4 MG?\n\nSAMIGLUTIDE 4 MG is a semaglutide-containing injectable formulation described as 4 mg/3 mL, supplied in a pre-filled pen. Its approved use depends on the regulatory authorization applicable to the product and market.\n\nWhat does 4 mg/3 mL mean?\n\nIt indicates that the stated 3 mL presentation contains a total of 4 mg of semaglutide, equivalent to approximately 1.34 mg of semaglutide per mL.\n\nThis concentration alone should not be used to determine an individual's injection dose.\n\nIs SAMIGLUTIDE 4 MG a prescription medicine?\n\nSemaglutide medicines are prescription products in many jurisdictions. SAMIGLUTIDE 4 MG should be used only in accordance with applicable regulations, authorized product information, and professional medical advice.\n\nHow is SAMIGLUTIDE 4 MG administered?\n\nThe product is described as a subcutaneous injection. However, the exact dose, injection frequency, and pen operation should be determined from the SAMIGLUTIDE 4 MG product information and the patient's prescription.\n\nCan SAMIGLUTIDE 4 MG be taken together with another semaglutide medicine?\n\nPatients should not combine semaglutide-containing medicines or switch between them without medical supervision. Some approved semaglutide labels specifically advise against combining their product with another semaglutide-containing medicine or another GLP-1 receptor agonist.\n\nCan the dose be changed without consulting a doctor?\n\nNo. Patients should not increase, decrease, or otherwise modify the prescribed dose or injection schedule without guidance from their healthcare professional.\n\nConclusion\n\nSAMIGLUTIDE 4 MG – Semaglutide Injection 4 mg/3 mL (approximately 1.34 mg/mL) Pre-Filled Pen is a semaglutide-based injectable formulation designed for subcutaneous use according to its applicable product instructions.\n\nBecause semaglutide products can vary substantially in their approved indications, concentrations, devices, and dosing regimens, information from another semaglutide product should not be assumed to apply to SAMIGLUTIDE 4 MG.\n\nFor appropriate and safe use, patients and healthcare professionals should rely on the current official product information, local regulatory authorization, and individualized medical advice. Any questions concerning suitability, dosing, interactions, contraindications, or adverse effects should be discussed with a qualified healthcare professional.", "price": 6600.0, "discountamount": 1980.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2497, "imageuri": "https://productimages.withfloats.com/actual/6a8c383c0e00e8a5dab0c9d5.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a8c383c0e00e8a5dab0c9d5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-24T12:25:28.659Z", "updatedon": "2026-08-24T12:25:28.659Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/semaglutide-injection-4mg/2497", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "SAMIGLUTIDE 4 MG", "category": "DIABETIC RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a6dedd85b0d81b5d5e65e09", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Olanzapine Mouth Dissolving Tablets 2.5 mg", "description": "OLANZPRIME 2.5 is a high-quality pharmaceutical formulation containing Olanzapine 2.5 mg in a convenient mouth dissolving tablet (MDT) dosage form. Developed to support the management of various psychiatric disorders, this formulation is designed to deliver effective therapy while improving patient convenience and treatment adherence. Manufactured in GMP-certified facilities using premium pharmaceutical ingredients, OLANZPRIME 2.5 is produced under strict quality control standards to ensure safety, purity, and consistent performance.\n\nThe rapidly dissolving tablet is formulated to disintegrate quickly on the tongue without the need for water, making it an ideal option for patients who have difficulty swallowing conventional tablets. Its user-friendly dosage form enhances ease of administration while providing dependable therapeutic support under the supervision of a qualified healthcare professional.\n\nComposition\n\nBrand Name: OLANZPRIME 2.5\n\nGeneric Name: Olanzapine\n\nStrength: 2.5 mg\n\nDosage Form: Mouth Dissolving Tablet (MDT)\n\nWhat is OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 contains Olanzapine, an atypical antipsychotic medication that works by regulating the activity of important neurotransmitters such as dopamine and serotonin. By helping restore the balance of these chemical messengers, the medicine supports improved emotional stability, clearer thinking, better behavioral control, and overall mental health.\n\nIts mouth dissolving formulation is specifically designed to provide greater convenience, particularly for individuals who experience difficulty swallowing standard oral tablets.\n\nUses of OLANZPRIME 2.5\n\nOLANZPRIME 2.5 may be recommended by healthcare professionals for the treatment and long-term management of various psychiatric conditions, including:\n\nSchizophrenia\nBipolar disorder, including manic and mixed episodes\nMaintenance therapy for bipolar disorder\nManagement of psychotic symptoms\nSelected behavioral or psychiatric conditions as determined by a physician\n\nThe appropriate dosage and duration of therapy should always be decided by a qualified healthcare provider based on the patient's individual clinical needs.\n\nBenefits of OLANZPRIME 2.5\nQuick-Dissolving Technology\n\nThe tablet dissolves rapidly in the mouth without requiring water, making administration simple and convenient.\n\nImproved Patient Adherence\n\nThe easy-to-take formulation is especially beneficial for elderly patients and individuals with swallowing difficulties, helping improve compliance with prescribed treatment.\n\nProven Antipsychotic Therapy\n\nOlanzapine is a well-established atypical antipsychotic used by healthcare professionals to help manage symptoms associated with schizophrenia and bipolar disorder.\n\nManufactured to High Pharmaceutical Standards\n\nProduced under strict GMP guidelines, OLANZPRIME 2.5 undergoes comprehensive quality testing to ensure consistent safety, efficacy, and product reliability.\n\nConvenient Anytime Administration\n\nThe mouth dissolving dosage form offers flexibility and ease of use, even when drinking water is not readily available.\n\nHow OLANZPRIME 2.5 Works\n\nOlanzapine belongs to the atypical antipsychotic class of medicines. It acts by modulating the activity of dopamine and serotonin receptors in the brain, helping restore a healthy balance of neurotransmitters involved in mood, perception, and behavior.\n\nThis therapeutic action may help reduce symptoms such as:\n\nHallucinations\nDelusional thoughts\nAgitation\nMood fluctuations\nDisorganized thinking\nAnxiety associated with certain psychiatric conditions\n\nWith regular use as prescribed, OLANZPRIME 2.5 helps support mental stability and improves overall quality of life for many patients.\n\nDosage and Administration\n\nTake OLANZPRIME 2.5 exactly as directed by your healthcare professional.\n\nGeneral administration guidelines include:\n\nPlace the tablet directly on the tongue.\nAllow it to dissolve completely before swallowing.\nWater is generally not required.\nTake the medication at the same time each day whenever possible.\nContinue treatment for the duration recommended by your physician.\nDo not stop taking the medicine without medical advice.\nPossible Side Effects\n\nLike all prescription medicines, OLANZPRIME 2.5 may cause side effects in some individuals, although not everyone experiences them.\n\nCommon side effects may include:\n\nDrowsiness\nDizziness\nDry mouth\nIncreased appetite\nWeight gain\nConstipation\nTiredness\n\nSerious or unusual symptoms require prompt medical evaluation. Always consult your healthcare provider if side effects become persistent or concerning.\n\nPrecautions and Warnings\n\nBefore starting OLANZPRIME 2.5, inform your healthcare provider if you have:\n\nDiabetes mellitus\nLiver disorders\nHeart disease\nEpilepsy or seizure disorders\nHigh cholesterol or lipid abnormalities\nHistory of stroke\nKidney impairment\nKnown allergy to Olanzapine or any ingredient in the formulation\n\nAlcohol consumption should generally be avoided during treatment, as it may increase drowsiness and other central nervous system effects.\n\nStorage Instructions\n\nTo preserve product quality:\n\nStore in a cool and dry place.\nProtect from direct sunlight and excessive moisture.\nKeep below the storage temperature mentioned on the product packaging.\nStore in the original blister pack until use.\nKeep out of the reach of children.\nWhy Choose OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 combines trusted antipsychotic therapy with the convenience of mouth dissolving technology, making it an excellent option for patients who require easy administration without compromising treatment effectiveness.\n\nKey Advantages\n\nPremium-quality Olanzapine 2.5 mg formulation\nRapid mouth dissolving tablet for easy administration\nNo water required for consumption\nSupports improved medication compliance\nManufactured under stringent GMP quality standards\nReliable dosage accuracy and product consistency\nSecure packaging designed to maintain product stability\nFrequently Asked Questions (FAQs)\nWhat is OLANZPRIME 2.5 prescribed for?\n\nOLANZPRIME 2.5 is prescribed for the treatment and management of schizophrenia, bipolar disorder, and other psychiatric conditions as determined by a qualified healthcare professional.\n\nDoes this tablet need to be taken with water?\n\nNo. The mouth dissolving tablet is designed to dissolve on the tongue, allowing convenient administration without water.\n\nCan I discontinue OLANZPRIME 2.5 without consulting my doctor?\n\nNo. Treatment should not be stopped suddenly, as abrupt discontinuation may increase the risk of symptom recurrence or withdrawal effects. Always seek medical advice before making any changes to your medication.\n\nIs OLANZPRIME 2.5 appropriate for older adults?\n\nHealthcare professionals may prescribe this medicine for elderly patients when clinically appropriate. Individual dosage adjustments may be necessary depending on the patient's overall health and medical history.\n\nHow long should treatment continue?\n\nThe duration of therapy varies according to the patient's diagnosis, treatment response, and clinical condition. Your healthcare provider will determine the most appropriate treatment plan and monitor progress throughout therapy.", "price": 60.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2489, "imageuri": "https://productimages.withfloats.com/actual/6a6deddbc0246085c8f7252b.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6deddbc0246085c8f7252b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T13:00:08.65Z", "updatedon": "2026-08-01T13:00:08.65Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-2-5-mg/2489", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME 2.5", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a6dec4d7747964c2eea9a0f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Metoprolol Succinate & Hydrochlorthiazide Extended Release Tablets", "description": "METAPROLATE H 50/12.5 is a premium antihypertensive medication formulated with Metoprolol Succinate Extended Release 50 mg and Hydrochlorothiazide 12.5 mg. This dual-action combination is intended for the treatment of hypertension (high blood pressure) in adults who require combination therapy for better blood pressure control. By combining two well-established medicines with complementary mechanisms of action, the formulation helps support long-term cardiovascular health while offering the convenience of once-daily dosing.\n\nManufactured in GMP-certified facilities using high-quality pharmaceutical ingredients, METAPROLATE H 50/12.5 is produced under rigorous quality assurance protocols to ensure safety, efficacy, and batch-to-batch consistency. The extended-release technology allows a gradual release of Metoprolol throughout the day, providing sustained therapeutic effects and helping maintain stable blood pressure levels.\n\nComposition\n\nBrand Name: METAPROLATE H 50/12.5\n\nGeneric Name: Metoprolol Succinate Extended Release & Hydrochlorothiazide Tablets\n\nEach Extended Release Tablet Contains:\n\nMetoprolol Succinate Extended Release – 50 mg\nHydrochlorothiazide – 12.5 mg\n\nDosage Form: Extended Release Tablets\n\nTherapeutic Category: Antihypertensive Medication\n\nWhat is METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 combines a beta-blocker and a thiazide diuretic to provide comprehensive blood pressure management.\n\nMetoprolol Succinate selectively blocks beta-1 receptors in the heart, reducing heart rate and decreasing the workload on the cardiovascular system. Hydrochlorothiazide acts as a diuretic by helping the body eliminate excess sodium and water through urine, lowering blood volume and contributing to reduced blood pressure.\n\nTogether, these medicines offer a complementary approach to hypertension treatment and may help lower the risk of complications associated with persistently elevated blood pressure, including stroke, heart attack, and kidney damage, when used according to medical advice.\n\nUses of METAPROLATE H 50/12.5\n\nHealthcare professionals may prescribe METAPROLATE H 50/12.5 for:\n\nManagement of essential hypertension\nPatients requiring combination antihypertensive therapy\nLong-term maintenance of healthy blood pressure levels\nReducing cardiovascular risks associated with uncontrolled hypertension\nSupporting comprehensive blood pressure management alongside lifestyle modifications\n\nThis medicine should always be used under the supervision of a qualified healthcare professional.\n\nBenefits of METAPROLATE H 50/12.5\nDual-Action Blood Pressure Control\n\nThe combination of Metoprolol Succinate and Hydrochlorothiazide addresses hypertension through two different therapeutic pathways, providing effective blood pressure reduction.\n\nSustained Drug Release\n\nThe extended-release formulation delivers Metoprolol gradually over 24 hours, helping maintain stable therapeutic levels and consistent blood pressure control.\n\nConvenient Once-Daily Administration\n\nA single daily dose simplifies long-term treatment and may improve patient adherence to prescribed therapy.\n\nSupports Cardiovascular Health\n\nMaintaining optimal blood pressure with appropriate treatment can help reduce the likelihood of serious cardiovascular complications over time.\n\nManufactured to High Quality Standards\n\nEvery batch is produced using premium pharmaceutical ingredients under strict GMP guidelines, ensuring reliable quality, safety, and consistency.\n\nHow METAPROLATE H 50/12.5 Works\n\nThe effectiveness of METAPROLATE H 50/12.5 is based on the complementary actions of its two active ingredients.\n\nMetoprolol Succinate works by selectively blocking beta-1 adrenergic receptors in the heart, which helps:\n\nSlow the heart rate\nReduce the force of cardiac contractions\nDecrease oxygen demand by the heart\nLower blood pressure\n\nHydrochlorothiazide works by promoting the removal of excess salt and water from the body through the kidneys. This helps:\n\nReduce circulating blood volume\nMinimize fluid retention\nLower blood pressure\nImprove overall cardiovascular function\n\nTogether, these mechanisms contribute to effective and sustained blood pressure management.\n\nDosage and Administration\n\nTake METAPROLATE H 50/12.5 exactly as prescribed by your physician.\n\nGeneral recommendations include:\n\nTake one tablet daily or as directed by your healthcare provider.\nSwallow the extended-release tablet whole with water.\nDo not crush, chew, or split the tablet unless specifically instructed.\nIt may be taken with or without food according to your doctor's advice.\nTake the medication at the same time each day to maintain consistent therapeutic levels.\nContinue treatment as prescribed, even if your blood pressure is well controlled, unless your doctor advises otherwise.\nPossible Side Effects\n\nAs with any prescription medicine, some individuals may experience side effects, although many people tolerate the medication well.\n\nCommonly reported side effects include:\n\nDizziness\nTiredness or fatigue\nSlow heartbeat\nHeadache\nIncreased urination\nNausea\nLow blood pressure\nChanges in electrolyte levels\n\nSeek immediate medical attention if you experience severe allergic reactions, breathing difficulties, fainting, persistent chest pain, or any other serious symptoms.\n\nConsult your healthcare provider if any side effect persists or becomes troublesome.\n\nPrecautions and Warnings\n\nBefore starting METAPROLATE H 50/12.5, inform your healthcare provider if you have:\n\nHeart rhythm abnormalities\nHeart failure\nAsthma or chronic respiratory disorders\nDiabetes mellitus\nKidney or liver impairment\nGout\nElectrolyte imbalance\nThyroid disorders\nAllergy to Metoprolol, Hydrochlorothiazide, sulfonamide-derived medicines, or any ingredient in this product\n\nRegular monitoring of blood pressure, heart rate, kidney function, and electrolyte levels may be recommended during treatment.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from excessive heat, moisture, and direct sunlight.\nKeep the tablets in their original packaging until use.\nStore at the temperature indicated on the product label.\nKeep out of the reach of children.\nWhy Choose METAPROLATE H 50/12.5?\n\nMETAPROLATE H 50/12.5 is formulated to provide dependable blood pressure management with the convenience of a once-daily extended-release dosage form. Manufactured according to stringent pharmaceutical quality standards, it combines two trusted antihypertensive agents in a single tablet, supporting improved treatment adherence and long-term cardiovascular care.\n\nKey Advantages\n\nExtended-release formulation for sustained therapeutic action\nCombination of two proven antihypertensive medicines\nConvenient once-daily dosing\nHigh-quality manufacturing with strict quality assurance\nReliable efficacy and consistent product performance\nSuitable for long-term hypertension management under medical supervision\nFrequently Asked Questions (FAQs)\nWhat is METAPROLATE H 50/12.5 prescribed for?\n\nIt is prescribed for the treatment of high blood pressure in adults who require combination antihypertensive therapy.\n\nHow does the extended-release formulation benefit patients?\n\nThe extended-release technology gradually releases Metoprolol throughout the day, helping maintain consistent blood levels and prolonged blood pressure control.\n\nCan I discontinue METAPROLATE H 50/12.5 on my own?\n\nNo. Beta-blockers should not be stopped suddenly, as abrupt discontinuation may increase cardiovascular risk. Always consult your healthcare provider before making any changes to your treatment.\n\nCan this medicine be used with other antihypertensive medications?\n\nYour doctor will determine whether additional blood pressure medicines are necessary based on your medical condition and treatment goals.\n\nHow long should treatment continue?\n\nHypertension is often a lifelong condition requiring continuous management. Continue taking METAPROLATE H 50/12.5 for the duration recommended by your healthcare professional, along with appropriate lifestyle modifications and regular medical follow-up.", "price": 248.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2488, "imageuri": "https://productimages.withfloats.com/actual/6a6dec4fc0246085c8f72513.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a6dec4fc0246085c8f72513.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-08-01T12:53:33.409Z", "updatedon": "2026-08-01T12:53:33.409Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//metoprolol-succinate-hydrochlorthiazide-extended-release-tablets/2488", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "METAPROLATE H 50/12.5", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a68576d4f0b0886fc04ae84", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Prednisolone Acetate Ophthalmic Suspension USP", "description": "Prednisolone Acetate Ophthalmic Suspension USP is a prescription corticosteroid eye drop formulated to reduce inflammation, redness, swelling, and discomfort associated with various eye conditions. It is commonly prescribed by ophthalmologists after eye surgery or for inflammatory eye disorders that respond to steroid treatment.\n\nThis ophthalmic suspension works by suppressing the body's inflammatory response, helping relieve symptoms such as eye pain, irritation, and light sensitivity while supporting the healing process. Because it is a prescription medicine, it should only be used under the supervision of a qualified healthcare professional.\n\nWhether you are a healthcare provider, pharmacy, hospital, or licensed distributor, choosing a reliable source for Prednisolone Acetate Ophthalmic Suspension USP ensures consistent quality, regulatory compliance, and patient safety.\n\nWhat Is Prednisolone Acetate Ophthalmic Suspension USP?\nPrednisolone Acetate Ophthalmic Suspension USP is a sterile corticosteroid eye suspension intended for ophthalmic use. It is designed to treat steroid-responsive inflammation affecting the anterior segment of the eye when bacterial, viral, or fungal infections have been ruled out or are being appropriately managed.\n\nDoctors may prescribe this medication for conditions including:\n\nPost-operative eye inflammation\nAllergic eye inflammation\nUveitis\nIritis\nCertain inflammatory eye disorders\nCorneal or conjunctival inflammation that responds to corticosteroids\nAlways use this medication exactly as directed by your eye care specialist.\n\nHow Does Prednisolone Acetate Ophthalmic Suspension USP Work?\nPrednisolone acetate belongs to the corticosteroid class of medicines. It works by reducing the release of inflammatory substances that cause swelling, redness, pain, and irritation within the eye.\n\nBy controlling inflammation, the medication helps:\n\nReduce eye redness\nMinimize swelling\nRelieve discomfort\nImprove patient comfort during recovery\nSupport healing following eye procedures\nThe suspension should be shaken well before each use to ensure even distribution of the active ingredient.\n\nKey Benefits\nPrednisolone Acetate Ophthalmic Suspension USP offers several important benefits when prescribed appropriately:\n\nHelps reduce eye inflammation quickly\nRelieves redness and swelling\nSupports recovery after ophthalmic surgery\nReduces eye discomfort and irritation\nSterile ophthalmic formulation\nSuitable for professional ophthalmic treatment plans\nManufactured according to pharmaceutical quality standards\nIndications\nYour healthcare provider may recommend Prednisolone Acetate Ophthalmic Suspension USP for:\n\nEye inflammation after cataract surgery\nSteroid-responsive conjunctival inflammation\nCorneal inflammation\nUveitis\nIritis\nAllergic inflammatory eye conditions\nOther ophthalmic inflammatory disorders as determined by an eye specialist\nThis medication should not be used without a prescription.\n\nDirections for Use\nUse Prednisolone Acetate Ophthalmic Suspension USP only as prescribed.\n\nGeneral instructions include:\n\nWash your hands before application.\nShake the bottle well.\nTilt your head back.\nInstill the prescribed number of drops into the affected eye.\nAvoid touching the dropper tip to any surface.\nClose the bottle tightly after use.\nFollow the complete treatment schedule even if symptoms improve.\nDo not stop treatment suddenly unless advised by your healthcare provider.\n\nPrecautions\nBefore using Prednisolone Acetate Ophthalmic Suspension USP, inform your doctor if you:\n\nHave glaucoma\nHave a viral, fungal, or bacterial eye infection\nWear contact lenses\nAre pregnant or breastfeeding\nHave recently undergone eye surgery\nAre allergic to corticosteroids\nLong-term or excessive use may increase the risk of elevated intraocular pressure, cataracts, or secondary eye infections. Regular eye examinations may be recommended during extended treatment.\n\nPossible Side Effects\nLike all medicines, Prednisolone Acetate Ophthalmic Suspension USP may cause side effects.\n\nCommon side effects may include:\n\nTemporary blurred vision\nMild burning or stinging\nEye irritation\nWatery eyes\nLess common but more serious effects may include:\n\nIncreased eye pressure\nDelayed wound healing\nCataract formation with prolonged use\nSecondary eye infections\nVision changes\nSeek prompt medical attention if you experience severe eye pain, sudden vision changes, significant redness, or signs of an allergic reaction.\n\nStorage Instructions\nStore Prednisolone Acetate Ophthalmic Suspension USP according to the instructions on the product label.\n\nGeneral recommendations include:\n\nStore at controlled room temperature.\nKeep the bottle tightly closed.\nProtect from excessive heat and direct sunlight.\nDo not freeze unless instructed by the manufacturer.\nKeep out of reach of children.\nDiscard the bottle after the recommended period following opening, as advised by your pharmacist or healthcare provider.\n\nWhy Choose Our Prednisolone Acetate Ophthalmic Suspension USP?\nWe are committed to supplying quality pharmaceutical products that meet applicable manufacturing standards. Our products are carefully handled to help maintain product integrity throughout storage and distribution.\n\nWe offer:\n\nHigh-quality pharmaceutical products\nSecure packaging\nReliable supply\nBulk order support\nTimely delivery\nResponsive customer assistance\nFor product specifications, availability, and ordering information, please contact our sales team.\n\nFrequently Asked Questions (FAQs)\n1. What is Prednisolone Acetate Ophthalmic Suspension USP used for?\nIt is used to treat steroid-responsive inflammation of the eye, including inflammation following eye surgery and certain inflammatory eye conditions, when prescribed by a healthcare professional.\n\n2. Is Prednisolone Acetate Ophthalmic Suspension USP an antibiotic?\nNo. It is a corticosteroid that reduces inflammation. It does not treat bacterial infections.\n\n3. Do I need a prescription?\nYes. Prednisolone Acetate Ophthalmic Suspension USP should only be used under the guidance of a licensed healthcare provider.\n\n4. How long should I use these eye drops?\nThe duration of treatment depends on your diagnosis and your doctor's recommendation. Do not discontinue treatment without medical advice.\n\n5. Should I shake the bottle before use?\nYes. As an ophthalmic suspension, the bottle should be shaken well before each application to ensure the medication is evenly mixed.\n\n6. Can I wear contact lenses while using Prednisolone Acetate Ophthalmic Suspension USP?\nYour eye care professional may advise you to avoid wearing contact lenses during treatment, especially if your eyes are inflamed or recovering from surgery.\n\n7. What happens if I miss a dose?\nUse the missed dose as soon as you remember unless it is nearly time for your next scheduled dose. Do not use extra medication to make up for a missed dose.\n\n8. Can these eye drops cause blurred vision?\nTemporary blurred vision may occur immediately after application. Wait until your vision clears before driving or operating machinery.\n\n9. Are there any serious side effects?\nLong-term use may increase the risk of elevated intraocular pressure, cataracts, delayed healing, or secondary infections. Regular follow-up appointments are important if prolonged treatment is required.\n\n10. How should Prednisolone Acetate Ophthalmic Suspension USP be stored?\nStore it according to the product labeling, keep the bottle tightly closed, protect it from excessive heat and light, and keep it out of the reach of children.\n\n11. Can children use Prednisolone Acetate Ophthalmic Suspension USP?\nUse in children should only occur when prescribed and monitored by a qualified healthcare professional.\n\n12. Can I use Prednisolone Acetate Ophthalmic Suspension USP for red eyes without consulting a doctor?\nNo. Red eyes can have many causes, including infections that may worsen with corticosteroid treatment. Always consult an eye care professional before using steroid eye drops.\n\nIf you're targeting SEO for a pharmaceutical manufacturer, wholesaler, or exporter, I can also tailor this page for commercial/B2B intent while keeping it medically responsible and aligned with search quality guidelines.\n", "price": 62.0, "discountamount": 18.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2485, "imageuri": "https://productimages.withfloats.com/actual/6a685772440c6b3927c66b54.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a685772440c6b3927c66b54.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-28T07:17:01.827Z", "updatedon": "2026-07-28T07:17:01.827Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//prednisolone-acetate-ophthalmic-suspension-usp/2485", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION PREDNISOLONE 1%", "category": "Opthalmology Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a68501b7848bdec5254a606", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Potassium Iodide,Calcium Chloride & Sodium Chloride Eye Drops", "description": "Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops are specially formulated ophthalmic drops used to support eye health and help manage certain corneal conditions under medical supervision. This unique combination works by improving the natural healing process of the cornea while helping reduce corneal opacity and assisting in the absorption of abnormal calcium deposits in selected eye disorders. Ophthalmologists may prescribe these eye drops for patients experiencing corneal degeneration, corneal scars, or other conditions affecting the transparency of the cornea.\n\nIf you are looking for an effective eye care solution recommended by eye specialists, Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops offer a clinically trusted option. Before purchasing, it is essential to understand their uses, benefits, dosage, precautions, and possible side effects to ensure safe and effective treatment.\n\nWhat are Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops?\n\nPotassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops are prescription ophthalmic drops formulated to improve corneal health and support recovery from specific eye conditions involving corneal opacity or calcium deposition.\n\nEach ingredient plays an important role:\n\nPotassium Iodide helps promote the absorption of abnormal corneal deposits and supports corneal healing.\nCalcium Chloride maintains electrolyte balance necessary for healthy eye tissues.\nSodium Chloride helps maintain proper osmotic pressure and provides hydration to the ocular surface.\n\nTogether, these ingredients help preserve corneal clarity, improve comfort, and support better visual function when used as directed by an ophthalmologist.\n\nUses of Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops\n\nDoctors may prescribe these eye drops for several ophthalmic conditions, including:\n\nTreatment of corneal opacity\nManagement of superficial corneal scars\nCorneal degeneration\nSupportive treatment in corneal calcium deposits\nPost-corneal injury recovery\nCertain chronic corneal disorders\nImproving corneal transparency\nSupporting healing after eye surgery (when advised)\nAdjunct therapy in selected ophthalmic conditions\n\nThese eye drops should always be used according to an eye specialist's recommendation.\n\nBenefits of Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops\n\nUsing these eye drops as prescribed offers several advantages:\n\nHelps reduce corneal opacity\nSupports natural corneal healing\nAssists in dissolving abnormal calcium deposits\nMaintains healthy electrolyte balance in eye tissues\nHelps preserve corneal transparency\nImproves ocular lubrication\nReduces eye discomfort associated with corneal disorders\nSupports better visual clarity\nSuitable for long-term ophthalmic management when recommended\nEasy-to-use sterile eye drop formulation\nHow Do Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops Work?\n\nThe effectiveness of this ophthalmic formulation comes from the combined action of its active ingredients.\n\nPotassium Iodide is believed to facilitate the gradual absorption of certain corneal deposits and support tissue repair. It has traditionally been used in ophthalmology to manage corneal opacities and related disorders.\n\nCalcium Chloride contributes to maintaining normal cellular function and electrolyte balance within ocular tissues, supporting healthy corneal physiology.\n\nSodium Chloride helps regulate osmotic balance, reduces excess fluid accumulation, and keeps the eye surface adequately hydrated.\n\nTogether, these ingredients help restore a healthier corneal environment and improve overall eye comfort.\n\nHow to Use Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops\n\nFor the best results:\n\nWash your hands thoroughly.\nShake the bottle if instructed.\nTilt your head backward.\nPull the lower eyelid downward.\nInstill the prescribed number of drops.\nClose your eyes gently for 1–2 minutes.\nAvoid touching the dropper tip.\nReplace the cap tightly after each use.\n\nAlways follow your ophthalmologist's dosage instructions.\n\nRecommended Dosage\n\nThe dosage depends on:\n\nAge\nEye condition\nSeverity of disease\nMedical history\nResponse to treatment\n\nMost patients are advised to use the drops 2–4 times daily, but only your ophthalmologist can determine the correct dosage.\n\nDo not increase or decrease the frequency without medical advice.\n\nPossible Side Effects\n\nLike all medications, these eye drops may cause mild side effects.\n\nCommon side effects include:\n\nMild burning sensation\nTemporary eye irritation\nWatery eyes\nRedness\nMild itching\nTemporary blurred vision after instillation\n\nRare side effects include:\n\nAllergic reaction\nPersistent eye pain\nSevere redness\nSwelling around the eyes\nVision changes\n\nSeek immediate medical attention if severe symptoms occur.\n\nPrecautions Before Using These Eye Drops\n\nBefore using Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops, inform your doctor if you have:\n\nAllergy to iodine or any ingredient\nThyroid disorders\nRecent eye surgery\nEye infection\nContact lens use\nPregnancy\nBreastfeeding\nOther ongoing eye medications\n\nAvoid sharing your eye drops with others.\n\nDrug Interactions\n\nInform your doctor if you are using:\n\nOther prescription eye drops\nAntibiotic eye medications\nSteroid eye drops\nLubricating eye drops\nAnti-glaucoma medications\nEye ointments\n\nMaintain a gap of at least 10–15 minutes between different eye medications unless instructed otherwise.\n\nWho Should Buy Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops?\n\nThese eye drops may be suitable for:\n\nPatients with corneal opacity\nIndividuals recovering from corneal injury\nPeople with chronic corneal degeneration\nPatients requiring supportive corneal therapy\nIndividuals advised by ophthalmologists for corneal calcium deposits\n\nThey are not meant for self-medication and should only be purchased after medical consultation.\n\nStorage Instructions\n\nStore the bottle:\n\nBelow 25°C\nAway from sunlight\nKeep tightly closed\nDo not freeze\nKeep away from children\nDiscard within the recommended period after opening, as advised on the label\nWhy Choose Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops?\n\nPatients and healthcare professionals prefer this ophthalmic formulation because it:\n\nSupports corneal recovery\nHelps maintain eye tissue health\nOffers a balanced electrolyte formulation\nIs easy to administer\nComes in a sterile ophthalmic solution\nIs prescribed by ophthalmologists for selected corneal disorders\nSupports long-term eye care under medical supervision\nBuying Guide\n\nWhen purchasing Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops, make sure you:\n\nBuy from a trusted pharmacy or authorized online medical store.\nVerify the manufacturing and expiry dates.\nEnsure the bottle is properly sealed.\nUse only on the advice of an ophthalmologist.\nRead the patient information leaflet before use.\nStore the bottle correctly after opening.\nFrequently Asked Questions (FAQs)\n1. What are Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops used for?\n\nThese eye drops are mainly prescribed to support the treatment of corneal opacity, corneal degeneration, and certain corneal calcium deposits under an ophthalmologist's supervision.\n\n2. Can these eye drops improve vision?\n\nThey do not directly improve eyesight but may help improve corneal clarity in suitable patients, which can contribute to better vision depending on the underlying condition.\n\n3. Are these eye drops safe for long-term use?\n\nThey may be used for extended periods only if recommended and regularly monitored by your eye specialist.\n\n4. Can I wear contact lenses while using these eye drops?\n\nIt is generally advisable to remove contact lenses before application and reinsert them only after the time recommended by your doctor or the product instructions.\n\n5. How many times should I use these eye drops daily?\n\nUse them exactly as prescribed by your ophthalmologist. Do not change the dosing schedule without medical advice.\n\n6. Can children use Potassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops?\n\nChildren should use these eye drops only when prescribed by a qualified ophthalmologist.\n\n7. What should I do if I miss a dose?\n\nApply the missed dose as soon as you remember unless it is almost time for your next scheduled dose. Do not use extra drops to make up for a missed dose.\n\n8. Can these eye drops cause blurred vision?\n\nTemporary blurred vision may occur immediately after instillation. Avoid driving or operating machinery until your vision becomes clear.\n\n9. Are these eye drops available without a prescription?\n\nAvailability depends on local regulations, but they should only be used under medical supervision due to their specialized ophthalmic indications.\n\n10. Can these eye drops be used with other eye medications?\n\nYes, but keep a gap of at least 10–15 minutes between different eye medications unless your ophthalmologist advises otherwise.\n\n11. How long does one bottle last?\n\nThe duration depends on the prescribed dosage. Always discard the bottle according to the manufacturer's instructions after opening.\n\n12. Who should avoid using these eye drops?\n\nPeople with known allergies to iodine or any ingredient, untreated eye infections, or specific medical conditions should consult their doctor before use.\n\nConclusion\n\nPotassium Iodide, Calcium Chloride & Sodium Chloride Eye Drops are a specialized ophthalmic formulation designed to support corneal health, reduce corneal opacity, and assist in the management of selected corneal disorders. When used under the guidance of an ophthalmologist, these eye drops can contribute to healthier corneal tissue, improved ocular comfort, and better visual outcomes. Always follow the prescribed dosage, maintain proper eye hygiene, and attend regular follow-up appointments to achieve the best treatment results. This balanced formulation remains a trusted option for patients seeking effective support for corneal care and long-term eye health.", "price": 105.0, "discountamount": 32.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2483, "imageuri": "https://productimages.withfloats.com/actual/6a68501e9f60f1b86cca589e.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a68501e9f60f1b86cca589e.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-28T06:45:47.031Z", "updatedon": "2026-07-28T06:45:47.031Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//potassium-iodide-calcium-chloride-sodium-chloride-eye-drops/2483", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION SODICLOR 3D", "category": "Opthalmology Range", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5df739c15b0b6844e869c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Olanzapine Mouth Dissolving Tablets 20 mg", "description": "OLANZPRIME 20 is a 20 mg Olanzapine mouth-dissolving tablet used to manage schizophrenia and bipolar disorder, typically for patients whose psychiatrist has determined a higher dose is appropriate than the standard 15 mg strength. It calms overactive dopamine and serotonin signaling in the brain, easing hallucinations, delusions, and mood instability. The tablet dissolves on the tongue in seconds, so no water is needed — a practical advantage for elderly patients or anyone who struggles with swallowing. Because higher-dose Olanzapine carries a somewhat greater chance of metabolic side effects like weight gain, regular monitoring is often advised. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nOLANZPRIME 20 Price – Olanzapine 20mg MD Tablet (Recommended)\nOLANZPRIME 20mg – Mouth Dissolving Antipsychotic\nOLANZPRIME 20 Price – Higher-Dose Olanzapine MD\nOlanzapine 20mg MD Tablet – OLANZPRIME Price Online\nOLANZPRIME 20 – Schizophrenia & Bipolar MD Tablet\n\nRationale: Option 1 leads with the “Price” anchor required for this Schedule H product and specifies the 20 mg strength clearly, helping differentiate it in search from the 15 mg SKU while staying within character limits.\n\nMeta Description (140–160 characters)\n\nOLANZPRIME 20 delivers higher-dose Olanzapine in an MD tablet for schizophrenia & bipolar care. Check price online. Prescription only – doctor advised.\n\nFull CMS Article\nOLANZPRIME 20: Higher-Strength Olanzapine Mouth Dissolving Tablet for Psychiatric Care\nTL;DR / AI Mode Summary\n\nOLANZPRIME 20 provides Olanzapine at a 20 mg strength in a fast-dissolving tablet form, prescribed for schizophrenia, bipolar disorder, and related conditions where a psychiatrist determines a higher dose is clinically needed. Like other Olanzapine formulations, it works on dopamine and serotonin pathways to steady mood and reduce psychotic symptoms. The dissolving format skips the need for water, which helps with adherence in patients who find tablet-swallowing difficult. Given the higher strength, monitoring for metabolic changes — weight, blood sugar, lipids — is a routine part of long-term care.\n\nUnderstanding OLANZPRIME 20\n\nNot every patient responds the same way to a starting dose of Olanzapine. Where symptoms remain inadequately controlled at lower strengths, or where a psychiatrist's clinical judgment calls for a higher therapeutic level, OLANZPRIME 20 offers the 20 mg strength in the same convenient mouth-dissolving format — sparing patients the need to switch to swallowing multiple lower-strength tablets or handle water-based dosing.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tOLANZPRIME 20\nActive Ingredient\tOlanzapine\nStrength\t20 mg\nForm\tMouth Dissolving Tablet (MD)\nRoute\tOral\nTherapeutic Class\tAtypical Antipsychotic\nSchedule Status\tSchedule H – Prescription Only\nConditions It's Prescribed For\nSchizophrenia\nBipolar I Disorder, including acute manic episodes\nLong-term maintenance care for bipolar disorder\nPsychotic disorders more broadly\nMood disorders, at a psychiatrist's discretion\nAgitation linked to certain psychiatric presentations\n\nThe aim across these conditions is the same: dial down hallucinations, delusions, and disorganized thought enough that patients can re-engage with daily routines and relationships.\n\nMechanism of Action\n\nSymptoms like hallucinations, mood swings, and confused thinking are strongly linked to overactive dopamine (D2) receptor signaling, along with disrupted serotonin (5-HT2A) activity in the brain.\n\nAt the 20 mg strength, Olanzapine:\n\nBlocks excess dopamine receptor activity more fully than lower doses may achieve\nModulates serotonin signaling alongside dopamine\nEases hallucinations, delusions, and anxiety tied to psychotic symptoms\nSupports steadier mood and reduced aggression\nHelps restore clearer, more organized thinking\n\nThe mouth-dissolving format means the tablet breaks down on the tongue within moments, which is particularly useful for elderly patients or anyone managing swallowing difficulty alongside their psychiatric condition.\n\nDirections for Use\nTake OLANZPRIME 20 only in the dose and frequency your psychiatrist prescribes — do not self-adjust to a higher or lower strength.\nPlace the tablet on the tongue and let it dissolve fully without chewing.\nSwallow once dissolved; water isn't usually necessary.\nTake it at a consistent time each day.\nComplete the full course your doctor recommends, even if you start feeling better.\nNever stop abruptly — sudden discontinuation can trigger symptom relapse or withdrawal-type effects.\nPossible Side Effects\n\nCommon, generally manageable effects include:\n\nDrowsiness or sleepiness\nIncreased appetite\nWeight gain\nDry mouth\nConstipation\nDizziness\nFatigue\nTremors\nRestlessness\n\nLess common but more serious effects can include severe allergic reactions, uncontrolled muscle movements, very high fever, or signs of elevated blood sugar. Because the 20 mg strength is a higher dose, these metabolic and neurological effects warrant closer attention.\n\nPlaceholder: incidence rates and dose-comparison trial data pending qualified clinical reviewer sign-off before publication.\n\nSeek emergency care immediately if any of these serious symptoms appear.\n\nWho Should Be Cautious\n\nShare your full medical history with your doctor before starting, especially if you have:\n\nDiabetes or a family history of diabetes\nLiver or kidney disease\nHeart disease\nHigh cholesterol or triglycerides\nEpilepsy or seizure disorders\nGlaucoma\nParkinson's disease\nDementia, particularly in older patients\nA prior stroke\nPrecautions & Lifestyle Considerations\nAvoid alcohol, since it can compound drowsiness.\nBe cautious with driving or operating machinery until you know how the medicine affects you.\nBecause Olanzapine — especially at higher strengths — can contribute to weight gain, a balanced diet and regular activity are worth building into your routine.\nLong-term treatment typically includes periodic checks of blood sugar, lipid levels, and body weight.\nIn pregnancy or while breastfeeding, use only if your doctor has weighed the benefits against potential risks.\nStorage Instructions\nStore below 25°C, protected from moisture, heat, and direct sunlight.\nKeep tablets in the original blister pack until the moment of use.\nKeep out of reach of children.\nDo not use past the expiry date printed on the pack.\nComparing Olanzapine Strengths\nStrength\tTypical Scenario\tConsiderations\nOLANZPRIME 15 (15 mg)\tStandard starting or maintenance dose\tSuitable for many patients as an initial therapeutic level\nOLANZPRIME 20 (20 mg)\tHigher therapeutic need per psychiatrist's assessment\tMay carry a somewhat greater likelihood of metabolic side effects; monitoring emphasized\n\nNote: The right strength is determined entirely by a psychiatrist's clinical assessment — patients should never switch strengths on their own.\n\nWhy Choose OLANZPRIME 20?\n\nFor patients who need a higher Olanzapine dose but still benefit from a swallow-free administration route, OLANZPRIME 20 combines both. It's manufactured to consistent pharmaceutical quality standards, giving psychiatrists, hospitals, and pharmacies a dependable higher-strength option without sacrificing the ease-of-use that mouth-dissolving tablets are known for.\n\nConclusion\n\nManaging schizophrenia or bipolar disorder sometimes calls for a higher Olanzapine dose than a standard starting regimen provides. OLANZPRIME 20 delivers that strength in a mouth-dissolving format that keeps daily administration simple, even for patients who find conventional tablets difficult to manage. Taken consistently under a psychiatrist's supervision, with regular monitoring for metabolic changes, it supports steadier, more manageable day-to-day functioning. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is OLANZPRIME 20 used for? It's prescribed for schizophrenia, bipolar disorder, and other psychiatric conditions where a psychiatrist determines this higher strength is appropriate.\nHow is OLANZPRIME 20 different from OLANZPRIME 15? Both contain Olanzapine in the same mouth-dissolving format; OLANZPRIME 20 is a higher 20 mg strength used when a psychiatrist assesses that a greater dose is clinically needed.\nHow should I take it? Place the tablet on your tongue, let it dissolve fully, and swallow naturally — always following your doctor's exact dosing.\nDo I need water to take this tablet? No, it's designed to dissolve on the tongue without water.\nCan OLANZPRIME 20 cause weight gain? Yes, weight gain and increased appetite are known effects, and the risk may be somewhat higher at this strength — regular monitoring and healthy habits can help manage it.\nIs this strength safe for long-term use? Yes, under a psychiatrist's ongoing supervision, with periodic checks of weight, blood sugar, and lipid levels.\nCan I switch from OLANZPRIME 15 to OLANZPRIME 20 on my own? No — any change in strength must be directed by your prescribing psychiatrist.\nWhat happens if I stop taking it suddenly? Stopping abruptly can lead to symptom relapse or withdrawal-type effects; any discontinuation should be gradual and doctor-guided.\nDoes alcohol interact with OLANZPRIME 20? Yes, alcohol can intensify drowsiness and should generally be avoided during treatment.\nIs it safe to drive while taking this medicine? Use caution with driving or operating machinery until you understand how the medicine affects your alertness and coordination.\nWhat health conditions should I disclose before starting? Mention diabetes, liver or kidney disease, heart disease, high cholesterol, epilepsy, glaucoma, Parkinson's disease, dementia, or a history of stroke.\nWhat serious symptoms need immediate medical attention? Severe allergic reactions, uncontrolled muscle movements, very high fever, or signs of very high blood sugar require urgent care.\nCan this be used during pregnancy? Only under medical supervision, after your doctor weighs the potential benefits against risks.\nIs a prescription required to buy OLANZPRIME 20? Yes, it is a Schedule H medicine and can only be dispensed against a valid doctor's prescription.\nHow long until I notice improvement? This varies by individual and condition; your psychiatrist will track progress through scheduled follow-ups.\n\n[Steris Healthcare Footer] Manufactured and marketed by Steris Healthcare Pvt. Ltd. — a WHO-GMP and ISO-certified pharmaceutical manufacturer. For queries, reach us at contact@sterispharma.com or +91 8824175417. This content is for informational purposes only and does not replace professional medical advice. Prescription only – consult your doctor.", "price": 245.0, "discountamount": 73.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2479, "imageuri": "https://productimages.withfloats.com/actual/6a5df73c6c57d63669881829.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5df73c6c57d63669881829.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T10:23:53.814Z", "updatedon": "2026-07-20T10:23:53.814Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-20-mg/2479", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME 20", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a5df5b80932adf55b8b989e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Olanzapine Mouth Dissolving Tablets 15 mg", "description": "OLANZPRIME 15 is a mouth-dissolving tablet containing Olanzapine 15 mg, prescribed for schizophrenia and bipolar disorder. As an atypical antipsychotic, it works by rebalancing dopamine and serotonin activity in the brain, easing hallucinations, delusions, mood swings, and disorganized thinking. The dissolving format is built for patients who find swallowing standard tablets difficult, letting the tablet break down on the tongue without water. It's typically taken once daily at a consistent time, under a psychiatrist's supervision, and should never be stopped abruptly. Common effects include drowsiness and appetite changes. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nOLANZPRIME 15 Price – Olanzapine MD Tablet | Steris (Recommended)\nOLANZPRIME 15 – Olanzapine Mouth Dissolving Tablet\nOLANZPRIME 15 Price – Schizophrenia & Bipolar Care\nOlanzapine 15mg MD Tablet – OLANZPRIME Price\nOLANZPRIME 15 – Antipsychotic MD Tablet Online\n\nRationale: Option 1 leads with the required “Price” anchor for this Schedule H product, keeps the brand and dosage form searchable, and stays within the 50–60 character target.\n\nMeta Description (140–160 characters)\n\nOLANZPRIME 15 (Olanzapine 15mg MD) eases schizophrenia and bipolar symptoms. Check price online. Prescription only – consult your doctor before use.\n\nFull CMS Article\nOLANZPRIME 15: Olanzapine Mouth Dissolving Tablet for Schizophrenia and Bipolar Disorder\nTL;DR / AI Mode Summary\n\nOLANZPRIME 15 delivers Olanzapine 15 mg in a mouth-dissolving format, used in the treatment of schizophrenia and bipolar disorder. It belongs to the atypical antipsychotic class and acts on dopamine and serotonin pathways to ease hallucinations, delusions, mood instability, and disorganized thought. The dissolving tablet is especially useful for patients — including elderly or psychiatric patients — who struggle with swallowing regular pills. It is a Schedule H medicine and must be taken strictly as prescribed by a psychiatrist.\n\nWhat Is OLANZPRIME 15?\n\nOLANZPRIME 15 is built around Olanzapine, a second-generation (atypical) antipsychotic that psychiatrists prescribe to manage serious mental health conditions. Rather than a standard swallow-with-water tablet, this formulation is designed to break down on the tongue within seconds, which supports better adherence in patients who find conventional dosing forms hard to manage.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tOLANZPRIME 15\nActive Ingredient\tOlanzapine\nStrength\t15 mg\nForm\tMouth Dissolving Tablet (MD)\nTherapeutic Class\tAtypical Antipsychotic\nSchedule Status\tSchedule H – Prescription Only\nCommon Indications\nSchizophrenia\nBipolar I Disorder, including manic episodes\nLong-term maintenance therapy for bipolar disorder\nAcute agitation linked to psychotic episodes, under physician direction\nMood instability requiring antipsychotic support\nOther psychiatric conditions where antipsychotic therapy is indicated\n\nBy calming excess dopamine signaling, this medicine can reduce hallucinations, delusional thinking, and aggression, helping patients function more steadily day to day.\n\nMechanism of Action\n\nPsychiatric symptoms such as hallucinations, delusions, and racing or disorganized thoughts are closely tied to overactive dopamine (D2) signaling in the brain, alongside disruptions in serotonin (5-HT2A) pathways.\n\nOlanzapine works by:\n\nDampening excess dopamine receptor activity\nModulating serotonin receptor signaling\nReducing hallucinations and delusional thought patterns\nSupporting emotional and mood stability\nEasing agitation and aggressive behavior\nImproving focus and social engagement\nSupporting more restful sleep\n\nBecause the tablet dissolves directly in the mouth, it's absorbed without needing water, making it a practical option for elderly patients and those with swallowing difficulty.\n\nDirections for Use\nTake OLANZPRIME 15 only as your psychiatrist prescribes.\nPlace the tablet on the tongue and let it dissolve fully — do not chew.\nSwallow naturally once dissolved; water is generally not needed.\nTake it at the same time each day to build a consistent routine.\nNever stop the medicine abruptly without medical guidance, as sudden discontinuation can trigger withdrawal or relapse symptoms.\nPossible Side Effects\n\nMost side effects are mild and tend to ease as the body adjusts. These can include:\n\nDrowsiness\nDizziness\nIncreased appetite\nWeight gain\nDry mouth\nConstipation\nFatigue\nTremors\nRestlessness\n\nPlaceholder: incidence rates and comparative trial data pending qualified clinical reviewer sign-off before publication.\n\nGet emergency medical help if you experience a severe allergic reaction, uncontrollable muscle movements, high fever, confusion, or trouble breathing — these may indicate a rare but serious reaction.\n\nWho Should Be Cautious\n\nTell your doctor before starting OLANZPRIME 15 if you have:\n\nDiabetes\nLiver or kidney disease\nHeart conditions\nEpilepsy or seizure history\nHigh cholesterol\nObesity\nGlaucoma\nDementia\nA history of stroke\n\nAvoid alcohol during treatment, as it can intensify drowsiness. Pregnant or breastfeeding women should use this medicine only under close medical supervision, weighing benefits against risks with their doctor.\n\nPrecautions & Storage\nTake exactly as prescribed — never adjust the dose on your own.\nWatch for changes in weight, appetite, or blood sugar during long-term use, and report these to your doctor.\nDon't combine with alcohol or other sedating substances without medical advice.\nStore below 25°C, away from moisture and direct sunlight.\nKeep in the original packaging, out of reach of children.\nComparable Antipsychotic Options\nMedicine Type\tTypical Use Case\tDosage Form Convenience\nStandard Olanzapine Tablets\tSchizophrenia, bipolar disorder\tRequires water to swallow\nOLANZPRIME 15 (MD Tablet)\tSame indications, for patients with swallowing difficulty\tDissolves on tongue, no water needed\nOther Atypical Antipsychotics\tAlternate receptor profiles, physician's choice\tVaries by brand and formulation\n\nNote: Switching between antipsychotic medicines or formulations should only be done under a psychiatrist's guidance.\n\nWhy Choose OLANZPRIME 15?\n\nBeyond its therapeutic role in managing schizophrenia and bipolar disorder, OLANZPRIME 15's mouth-dissolving format addresses a real, practical barrier many psychiatric patients face — reliably swallowing tablets every day. Manufactured to consistent quality standards, it gives psychiatrists a dependable option for patients who need both clinical effectiveness and easier day-to-day administration.\n\nConclusion\n\nLiving with schizophrenia or bipolar disorder often means managing symptoms that affect mood, thought, and daily functioning. OLANZPRIME 15 is formulated to help rebalance the brain chemistry behind these symptoms, in a mouth-dissolving form that simplifies daily dosing for patients who struggle with conventional tablets. Used consistently and under a psychiatrist's care, it supports more stable, manageable day-to-day life. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is OLANZPRIME 15 used for? It's prescribed for schizophrenia, bipolar disorder, and related psychiatric conditions, under a doctor's guidance.\nHow should I take OLANZPRIME 15? Place it on your tongue, let it dissolve fully, and swallow naturally — follow your doctor's exact dosing instructions.\nDo I need water to take it? No, as a mouth-dissolving tablet it typically doesn't require water.\nCan it cause weight gain? Yes, increased appetite and weight gain are recognized effects in some patients; your doctor may recommend periodic monitoring.\nIs it safe for long-term use? Yes, under a psychiatrist's ongoing supervision with regular follow-up to track effectiveness and side effects.\nCan I stop taking it once I feel better? No — stopping suddenly can cause withdrawal effects or symptom relapse. Any change in dose must go through your doctor.\nDoes OLANZPRIME 15 interact with alcohol? Yes, alcohol can worsen drowsiness and should generally be avoided during treatment.\nIs it safe during pregnancy? It should only be used in pregnancy or breastfeeding under close medical supervision, after discussing risks and benefits with a doctor.\nWhat conditions should I disclose to my doctor before starting? Mention any history of diabetes, liver or kidney disease, heart conditions, epilepsy, high cholesterol, glaucoma, dementia, or stroke.\nCan this medicine affect blood sugar or cholesterol? It can, in some patients, which is why regular monitoring is often recommended during treatment.\nWhat should I do if I notice uncontrollable muscle movements? Seek immediate medical attention, as this can indicate a rare but serious reaction requiring urgent evaluation.\nCan elderly patients take OLANZPRIME 15? Yes, and the mouth-dissolving format is often specifically helpful for elderly patients with swallowing difficulty, but dosing should be carefully individualized by the prescriber.\nHow long does it take to see improvement? Response times vary by individual and condition; your psychiatrist will assess progress over scheduled follow-ups.\nCan OLANZPRIME 15 be taken with other psychiatric medicines? Only under medical supervision, as combinations need careful evaluation for interactions.\nIs a prescription required to purchase OLANZPRIME 15? Yes, it is a Schedule H medicine and can only be dispensed against a valid doctor's prescription.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2478, "imageuri": "https://productimages.withfloats.com/actual/6a5df5ba3a3f53b9d65c6aa2.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a5df5ba3a3f53b9d65c6aa2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-20T10:17:28.721Z", "updatedon": "2026-07-20T10:24:54.243Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-15-mg/2478", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OLANZPRIME 15", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a50a78a75263abd944f583a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Loteprednol Etabonate Ophthalmic Suspension", "description": "Loteprednol etabonate ophthalmic suspension is a prescription corticosteroid eye drop used to treat steroid-responsive inflammatory conditions of the eye, including post-surgical inflammation, allergic conjunctivitis, and certain forms of anterior uveitis. What sets loteprednol apart from older ophthalmic steroids is its “ester-based” chemical structure, which is designed to break down into inactive components after acting on eye tissue — giving it a comparatively lower risk of raising intraocular pressure (IOP) than traditional steroids like prednisolone or dexamethasone, while still delivering effective anti-inflammatory action. The typical dose is one to two drops in the affected eye, four times daily, or as directed, usually for a short, defined course rather than indefinite use. Common side effects include burning, stinging, and blurred vision, while prolonged or unsupervised use can still carry steroid-related risks such as elevated eye pressure. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Loteprednol Etabonate Ophthalmic Suspension?\nLoteprednol etabonate ophthalmic suspension is a topical corticosteroid formulated specifically for use in the eye. It belongs to a category sometimes referred to as “site-specific” or “soft” steroids — a design approach where the drug is engineered to be highly active at the site of application (the eye) but rapidly metabolized into inactive by-products once it has acted, reducing the potential for the cumulative steroid-related side effects seen with older ophthalmic corticosteroids.\nThis suspension is commonly prescribed for:\n\nManaging inflammation following eye surgery, such as cataract surgery\nTreating allergic conjunctivitis, including seasonal allergic conjunctivitis\nCertain anterior segment inflammatory conditions, such as uveitis, under specialist supervision\nGiant papillary conjunctivitis and other steroid-responsive ocular surface conditions\n\nBecause of its comparatively favorable IOP profile, loteprednol is often considered by ophthalmologists for patients who need effective anti-inflammatory therapy but may be at higher risk from more potent steroids — though it is important to note that no ophthalmic steroid is entirely free of IOP-related risk, and monitoring remains necessary.\n\nHow Does Loteprednol Etabonate Work? (Mechanism of Action)\n\nCorticosteroid receptor binding – Loteprednol etabonate binds to glucocorticoid receptors within ocular tissue, initiating anti-inflammatory gene expression changes.\nSuppression of inflammatory mediators – This binding reduces the production of key inflammatory substances, including prostaglandins and cytokines, that drive redness, swelling, and discomfort.\nReduced vascular permeability – By calming the inflammatory cascade, the drug helps reduce leakage of fluid and inflammatory cells into ocular tissue, easing swelling.\nEster-based metabolism – Unlike ketone-based steroids, loteprednol's ester structure allows ocular esterases to break it down into inactive metabolites after it exerts its effect, which is thought to underlie its comparatively lower propensity to raise intraocular pressure.\nLocalized anti-inflammatory effect – The net result is effective control of ocular surface and anterior segment inflammation with a more favorable safety profile than some older steroid formulations, when used for the intended short duration.\n\n\nClinical Indications\nIndicationDetailsPost-operative ocular inflammationCommon after cataract and other intraocular surgeriesAllergic conjunctivitisIncluding seasonal allergic conjunctivitisGiant papillary conjunctivitisOften associated with contact lens wearAnterior uveitisUnder specialist supervisionOther steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segmentAs directed by an ophthalmologist\nNot indicated for: viral (e.g., herpes simplex), fungal, or mycobacterial eye infections, where corticosteroid use can worsen the underlying condition.\n\nDosage & Administration\nParameterRecommendationStandard dose1–2 drops in the affected eye(s), typically 4 times dailyPost-surgical regimenOften started at higher frequency and tapered per surgeon's protocolShake before useYes — this is a suspension; shake well before each applicationDurationShort, defined course as prescribed; not intended for indefinite useTaperingGradual reduction recommended rather than abrupt discontinuation after extended useContact lensesRemove before instillation; reinsert only per your doctor's adviceMissed doseApply as soon as remembered; do not double the next dose\nImportant: Even with its comparatively favorable safety profile, loteprednol should be used strictly for the duration prescribed. Extended, unsupervised use is not recommended.\n\nKey Benefits\n\nEffective anti-inflammatory action for a range of steroid-responsive ocular conditions\nEster-based design associated with a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids\nUseful for patients needing steroid therapy who may be more sensitive to IOP elevation, under appropriate monitoring\nSuitable for both post-surgical inflammation control and allergic conjunctivitis management\nAvailable in a suspension formulation designed for good ocular surface contact\nOften used as part of a short, defined treatment course, reducing exposure duration compared to continuous long-term steroid regimens\n\n\nPrecautions\n\nUse strictly under ophthalmologist supervision — this is not an over-the-counter product\nNot suitable for viral, fungal, or mycobacterial eye infections\nEven with its favorable profile, prolonged use can still raise intraocular pressure in susceptible individuals — periodic IOP monitoring is recommended\nExtended use may increase the risk of cataract formation, as with other ophthalmic steroids\nMay mask signs of infection or delay wound healing if used inappropriately\nInform your doctor of any history of glaucoma, herpes eye infection, or corneal thinning before starting\nShake the suspension well before each use for accurate dosing\nAvoid touching the dropper tip to the eye or any surface\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nBurning or stinging sensation on instillation\nBlurred vision immediately after application\nEye discomfort or a foreign-body sensation\nMild eye redness\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nElevated intraocular pressure (comparatively less frequent than with older steroids, but still possible)\nDelayed wound healing\nSigns of secondary or masked ocular infection\nCataract progression with prolonged use\nAllergic reaction (eyelid swelling, itching, rash)\n\nDiscontinue and consult your ophthalmologist promptly if any serious symptom develops.\n\nComparison: Loteprednol vs. Other Ophthalmic Corticosteroids\nTreatmentClassIOP Risk ProfileBest Suited ForLoteprednol etabonate suspensionEster-based (“soft”) corticosteroidComparatively lowerPatients needing effective anti-inflammatory action with reduced IOP concernPrednisolone acetateKetone-based corticosteroidHigher with prolonged useRobust anti-inflammatory action; requires closer IOP monitoringDexamethasoneKetone-based corticosteroidHigher, potent effectSevere inflammatory conditions; typically shorter coursesFluorometholoneKetone-based corticosteroidModerateMild to moderate inflammation with somewhat reduced IOP risk\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueReported incidence of clinically significant IOP elevation with short-course loteprednol use[Placeholder – insert verified clinical trial statistic]Comparative IOP-elevation rate vs. prednisolone acetate in controlled studies[Placeholder – insert verified reference]Typical duration of post-operative loteprednol therapy[Placeholder – insert reference range]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Loteprednol Etabonate Ophthalmic Suspension\nThe price of loteprednol etabonate ophthalmic suspension varies depending on brand, pack size, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nLoteprednol etabonate ophthalmic suspension offers a valuable option for managing steroid-responsive ocular inflammation — from post-surgical recovery to allergic conjunctivitis — with a design intended to reduce the intraocular pressure risks historically associated with ophthalmic corticosteroids. While its ester-based structure gives it a comparatively favorable safety profile, it remains a steroid, and prolonged or unsupervised use can still carry risks such as elevated eye pressure, cataract progression, and delayed healing. For this reason, loteprednol should always be used for the specific duration prescribed, with appropriate tapering and regular ophthalmic follow-up, rather than as a long-term, self-managed therapy.\n\nFrequently Asked Questions\n\n1. What is loteprednol etabonate ophthalmic suspension used for?\nIt is used to treat steroid-responsive eye inflammation, including inflammation after eye surgery, allergic conjunctivitis, and certain anterior segment inflammatory conditions such as uveitis, under an ophthalmologist's guidance.\n\n2. Is loteprednol a steroid?\nYes, loteprednol etabonate is a corticosteroid. It is specifically designed with an ester-based structure intended to reduce the risk of raising intraocular pressure compared to some older ophthalmic steroids, though it still requires medical supervision.\n\n3. How long can I use loteprednol eye drops?\nLoteprednol is typically prescribed for a short, defined course as determined by your ophthalmologist, often with a tapering schedule. It is not intended for indefinite, unsupervised long-term use.\n\n4. Does loteprednol raise eye pressure?\nLoteprednol has a comparatively lower risk of raising intraocular pressure than some older ophthalmic steroids due to its ester-based design, but it can still cause elevated eye pressure in susceptible individuals, especially with prolonged use, so periodic monitoring is recommended.\n\n5. Can loteprednol cause cataracts?\nProlonged use of any ophthalmic corticosteroid, including loteprednol, can increase the risk of cataract formation, particularly posterior subcapsular cataracts, which is why short, supervised courses are recommended.\n\n6. How is loteprednol different from prednisolone acetate?\nLoteprednol has an ester-based chemical structure designed to break down into inactive components after acting on the eye, which is associated with a lower risk of raising intraocular pressure compared to prednisolone acetate, a ketone-based steroid with a higher IOP-elevation potential.\n\n7. Can loteprednol be used for allergic conjunctivitis?\nYes, loteprednol etabonate ophthalmic suspension is commonly used to manage allergic conjunctivitis, including seasonal allergic conjunctivitis, especially when symptoms are significant or not controlled by other treatments.\n\n8. Is loteprednol safe after cataract surgery?\nYes, loteprednol is frequently prescribed to manage post-operative inflammation following cataract surgery, typically as part of a tapering regimen directed by the operating ophthalmologist.\n\n9. Can loteprednol be used for viral eye infections?\nNo, loteprednol and other corticosteroids are not appropriate for viral eye infections such as herpes simplex keratitis, as steroids can worsen these conditions if used inappropriately.\n\n10. What are the common side effects of loteprednol eye drops?\nCommon side effects include burning or stinging upon application, temporary blurred vision, mild eye redness, and eye discomfort. These are usually mild and resolve quickly.\n11. Does loteprednol need to be shaken before use?\nYes, since it is a suspension, the bottle should be shaken well before each use to ensure the medication is evenly distributed.\n\n12. Can loteprednol be stopped suddenly?\nStopping abruptly, especially after extended use, is generally not recommended. A gradual tapering schedule, as advised by your ophthalmologist, helps prevent rebound inflammation.\n\n13. Is loteprednol safe for long-term daily use?\nNo, loteprednol is generally intended for short, supervised courses rather than continuous long-term daily use, due to steroid-related risks with prolonged exposure.\n\n14. Can contact lenses be worn while using loteprednol?\nIt's generally recommended to remove contact lenses before applying loteprednol and reinsert them only after the interval advised by your doctor.\n\n15. Who should avoid using loteprednol eye drops?\nPatients with active untreated viral, fungal, or mycobacterial eye infections, or known hypersensitivity to the medication, should avoid loteprednol unless specifically directed otherwise by their ophthalmologist.\n\n16. Can loteprednol be used in children?\nUse in children should only occur under the direct guidance and prescription of a pediatric ophthalmologist, based on individual clinical assessment.\n17. Does loteprednol cause blurred vision?\nTemporary blurred vision can occur immediately after instillation in some patients and usually resolves quickly. Persistent blurred vision should be reported to your doctor.", "price": 150.0, "discountamount": 45.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2471, "imageuri": "https://productimages.withfloats.com/actual/6a50a78cd95cad00a915a6d8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a50a78cd95cad00a915a6d8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T08:04:26.663Z", "updatedon": "2026-07-10T08:04:26.663Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//loteprednol-etabonate-ophthalmic-suspension/2471", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION LOPEDIUM 0.5%", "category": "Opthalmology Range", "tags": [ "Loteprednol Etabonate Ophthalmic Suspension", "loteprednol etabonate ophthalmic suspension uses", "loteprednol etabonate ophthalmic suspension uses in hindi", "loteprednol etabonate ophthalmic suspension in hindi", "loteprednol etabonate ophthalmic suspension eye drops uses", "loteprednol etabonate ophthalmic suspension eye drops", "loteprednol etabonate ophthalmic suspension use" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a50a30c9e1ef0fb4df551b0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "dorzolamide eye drops ip", "description": "Dorzolamide eye drops IP are a prescription ophthalmic solution used to lower elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Dorzolamide belongs to a class of drugs called carbonic anhydrase inhibitors, which work by reducing the production of aqueous humor (the fluid inside the eye), thereby lowering pressure within the eye. It is typically used two to three times daily and begins measurably lowering eye pressure within about 2 hours, though consistent long-term use is essential for sustained control. Common side effects include a temporary bitter or unusual taste in the mouth, burning or stinging on instillation, and blurred vision. Because dorzolamide is chemically a sulfonamide derivative, it should be used cautiously in patients with known sulfa allergies or significant kidney impairment, and only under an ophthalmologist's supervision. It is a Schedule H prescription-only medicine in India.\n\nWhat Is Dorzolamide Eye Drops IP?\nDorzolamide Eye Drops IP is a topical prescription medication used primarily to manage glaucoma and ocular hypertension — conditions characterized by abnormally elevated pressure inside the eye that, if left uncontrolled, can damage the optic nerve and lead to progressive, irreversible vision loss.\nThe “IP” designation indicates the formulation conforms to standards set out in the Indian Pharmacopoeia, ensuring consistent quality, purity, and potency.\nDorzolamide belongs to the carbonic anhydrase inhibitor (CAI) class of anti-glaucoma medications. Unlike oral carbonic anhydrase inhibitors (such as acetazolamide), which act systemically and often cause more pronounced side effects, topical dorzolamide is designed to act locally within the eye, offering effective IOP reduction with comparatively lower systemic exposure — though some systemic absorption can still occur.\nIt is frequently prescribed either as a standalone treatment or in combination with other IOP-lowering agents, such as beta-blockers (e.g., timolol) or prostaglandin analogues, when a single agent does not achieve adequate pressure control.\n\nHow Does Dorzolamide Work? (Mechanism of Action)\n\nAqueous humor production – The ciliary body inside the eye continuously produces aqueous humor, the clear fluid that maintains intraocular pressure and nourishes ocular tissues.\nCarbonic anhydrase enzyme – This enzyme, found in the ciliary body, plays a key role in the chemical reactions that generate bicarbonate ions, which drive fluid secretion into the eye.\nEnzyme inhibition – Dorzolamide inhibits carbonic anhydrase (specifically the II isoenzyme) within the ciliary processes.\nReduced fluid production – With the enzyme inhibited, bicarbonate-dependent fluid transport slows down, resulting in decreased aqueous humor formation.\nLowered intraocular pressure – Less fluid production means less pressure buildup inside the eye, helping protect the optic nerve from pressure-related damage over time.\n\n\nClinical Indications\nIndicationDetailsOpen-angle glaucomaPrimary indication; helps control chronic elevated IOPOcular hypertensionUsed to reduce elevated eye pressure even before glaucoma-related damage occursAdjunct therapyCombined with beta-blockers or prostaglandin analogues when monotherapy is insufficientPost-laser or post-surgical IOP spikesSometimes used short-term under specialist guidance\n\nDosage & Administration\nParameterRecommendationStandard dose (monotherapy)One drop in the affected eye(s), three times dailyStandard dose (with other IOP-lowering drops)Often reduced to twice daily when combined, per doctor's instructionsOnset of actionMeasurable IOP reduction typically begins within about 2 hoursPeak effectGenerally within a few hours of instillationIf using multiple eye dropsSpace different eye medications at least 10 minutes apartMissed doseApply as soon as remembered; skip if near the next scheduled dose — do not double upDuration of useLong-term, ongoing therapy as glaucoma is a chronic condition requiring continuous management\nNote: Consistency is critical — missed doses can allow intraocular pressure to rise, increasing the risk of progressive optic nerve damage.\n\nKey Benefits\n\nEffectively lowers intraocular pressure in both glaucoma and ocular hypertension\nActs locally in the eye, generally producing lower systemic side effects compared to oral carbonic anhydrase inhibitors\nCan be used as monotherapy or in combination with other classes of glaucoma medication for enhanced pressure control\nHelps protect the optic nerve from pressure-related damage with consistent long-term use\nAvailable in a well-established, pharmacopoeia-standardized formulation (IP grade)\nSuitable for long-term, chronic disease management in glaucoma patients\n\n\nPrecautions\n\nUse strictly as prescribed and do not adjust dosing without consulting your ophthalmologist\nInform your doctor if you have a known sulfonamide (sulfa) allergy, since dorzolamide is chemically related to sulfa drugs\nUse with caution in patients with significant kidney (renal) impairment, due to potential for systemic absorption\nNot typically recommended in patients with severe corneal disease without specialist evaluation\nIf using contact lenses, remove before instillation and reinsert only after the interval advised by your doctor\nRegular eye pressure monitoring and follow-up visits are essential during treatment\nInform your doctor of all other eye medications and systemic drugs you are using\nAvoid touching the dropper tip to the eye or any surface to prevent contamination\n\n\nSide Effects\nCommon (Usually Mild and Temporary)\n\nTemporary bitter or unusual taste in the mouth after application\nBurning or stinging sensation on instillation\nBlurred vision immediately after use\nEye redness or itching\nMild eye discomfort\n\nLess Common / Serious (Consult Your Doctor Promptly)\n\nSigns of an allergic reaction (rash, swelling, severe itching)\nPersistent eye pain or significant vision changes\nSigns of corneal problems (persistent redness, discharge, sensitivity to light)\nSystemic effects related to sulfonamide sensitivity, in rare cases\n\nIf any serious or persistent symptom occurs, discontinue use and contact your ophthalmologist immediately.\n\nComparison: Dorzolamide vs. Other Anti-Glaucoma Therapies\nTreatmentClassMechanismKey ConsiderationDorzolamide eye dropsCarbonic anhydrase inhibitorReduces aqueous humor productionSulfa-related caution; often used as adjunct therapyTimolol eye dropsBeta-blockerReduces aqueous humor production via a different pathwayCaution in asthma, heart conditionsLatanoprost / prostaglandin analoguesProstaglandin analogueIncreases aqueous humor outflowOnce-daily dosing; may darken iris/eyelash growthBrimonidineAlpha-2 agonistReduces production and increases outflowCan cause drowsiness, dry mouthOral acetazolamideSystemic carbonic anhydrase inhibitorReduces aqueous humor production systemicallyMore pronounced systemic side effects than topical dorzolamide\n\nKey Statistics (Placeholder — Pending Clinical Reviewer Verification)\nMetricValueAverage IOP reduction achieved with dorzolamide monotherapy[Placeholder – insert verified clinical trial statistic]Prevalence of open-angle glaucoma in adults over 40[Placeholder – insert epidemiological reference]Proportion of patients requiring combination glaucoma therapy[Placeholder – insert verified reference]\nAll statistics above are placeholders and must be verified and populated by a qualified clinical reviewer prior to publication.\n\nExpert Insight\n\n[Placeholder — Expert quote pending. To be added only after review and approval by a licensed ophthalmologist/medical reviewer associated with Steris Healthcare. Do not fabricate or publish without sign-off.]\n\n\nPrice of Dorzolamide Eye Drops IP\nThe price of dorzolamide eye drops IP varies depending on pack size, brand, and region. For current pricing, availability, and prescription verification, please consult your ophthalmologist or an authorized pharmacy.\nPrescription only – consult your doctor.\n\nConclusion\nDorzolamide Eye Drops IP play a well-established role in the long-term management of glaucoma and ocular hypertension, offering targeted, localized reduction of intraocular pressure through carbonic anhydrase inhibition. Whether used alone or alongside other classes of IOP-lowering medication, consistent, correctly timed use is essential to protect the optic nerve from progressive, irreversible damage. Because dorzolamide is a sulfonamide derivative with potential for systemic absorption, patients with sulfa allergies or kidney impairment should discuss suitability carefully with their ophthalmologist. As with all glaucoma therapy, regular monitoring and adherence to the prescribed regimen — rather than occasional or as-needed use — are what ultimately safeguard long-term vision.\n\nFrequently Asked Questions\n\n1. What is dorzolamide eye drops used for?\nDorzolamide eye drops are used to lower elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, helping protect the optic nerve from pressure-related damage.\n\n2. How long does it take dorzolamide to lower eye pressure?\nDorzolamide typically begins measurably lowering intraocular pressure within about 2 hours of application, though consistent, long-term use is needed to maintain stable pressure control over time.\n\n3. What are the side effects of dorzolamide?\nCommon side effects include a temporary bitter or unusual taste in the mouth, burning or stinging upon application, blurred vision, and mild eye redness or discomfort. Less commonly, allergic reactions or persistent eye irritation can occur and should be reported to a doctor.\n4. Does dorzolamide affect the kidneys?\nDorzolamide is a sulfonamide derivative, and although it is applied topically with generally low systemic absorption, caution is advised in patients with significant kidney impairment. Patients with known kidney disease or sulfa allergies should inform their doctor before starting treatment.\n\n5. How often should dorzolamide eye drops be used?\nDorzolamide is typically used three times daily as monotherapy, or twice daily when combined with other glaucoma medications, exactly as directed by your ophthalmologist.\n\n6. Can dorzolamide be used with other glaucoma eye drops?\nYes, dorzolamide is commonly combined with beta-blockers, prostaglandin analogues, or other IOP-lowering agents when a single medication does not achieve adequate pressure control. Different eye drops should be spaced at least 10 minutes apart.\n\n7. Is dorzolamide safe for long-term use?\nYes, dorzolamide is designed for long-term, ongoing use in chronic glaucoma management, provided it is used under regular ophthalmologist supervision with periodic eye pressure monitoring.\n\n8. Who should not use dorzolamide eye drops?\nPatients with known hypersensitivity to sulfonamides, significant kidney impairment, or specific contraindications identified by their doctor should use dorzolamide only under close medical supervision, if at all.\n\n9. Does dorzolamide cause blurred vision?\nTemporary blurred vision can occur immediately after applying dorzolamide. This is usually short-lived, but if it persists, you should consult your ophthalmologist.\n\n10. Can dorzolamide eye drops be used with contact lenses?\nIt's generally recommended to remove contact lenses before applying dorzolamide and reinsert them only after the interval advised by your doctor, as certain preservatives in eye drops can affect contact lens materials.\n\n11. What happens if I miss a dose of dorzolamide?\nApply the missed dose as soon as you remember, unless it is almost time for your next scheduled dose — in that case, skip the missed dose and continue your regular schedule. Do not double up doses.\n\n12. Why does dorzolamide cause a bitter taste?\nThe bitter taste occurs because a small amount of the eye drop drains through the tear duct into the nasal passage and throat, where it can be tasted. This is a recognized, generally harmless effect of topical carbonic anhydrase inhibitors.\n13. Is dorzolamide the same as timolol eye drops?\nNo. Dorzolamide is a carbonic anhydrase inhibitor, while timolol is a beta-blocker. Both lower eye pressure but through different mechanisms, and they are sometimes prescribed together for enhanced effect.\n\n14. Can dorzolamide be used during pregnancy?\nUse during pregnancy or breastfeeding should only occur under direct medical supervision. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding before starting dorzolamide.\n\n15. How is dorzolamide different from oral glaucoma medications?\nTopical dorzolamide acts locally in the eye and generally causes fewer systemic side effects than oral carbonic anhydrase inhibitors like acetazolamide, which act throughout the body and can cause more pronounced systemic effects.\n16. Can stopping dorzolamide suddenly cause problems?\nStopping dorzolamide abruptly can allow intraocular pressure to rise again, increasing the risk of progressive optic nerve damage. Always consult your ophthalmologist before discontinuing treatment.\n\n17. Does dorzolamide need to be refrigerated?\nStorage requirements can vary by brand and formulation; always follow the storage instructions printed on your specific product's packaging or as advised by your pharmacist.", "price": 350.0, "discountamount": 105.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2470, "imageuri": "https://productimages.withfloats.com/actual/6a50a30e9569e07de66607f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a50a30e9569e07de66607f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-07-10T07:45:16.262Z", "updatedon": "2026-07-10T07:45:16.262Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//dorzolamide-eye-drops-ip/2470", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CIPVISION DORZONIX 2%", "category": "Opthalmology Range", "tags": [ "dorzolamide eye drops ip", "dorzolamide eye drops", "dorzolamide eye drops uses", "dorzolamide eye drops uses in hindi", "dorzolamide eye drops price", "dorzolamide eye drops ip", "dorzolamide eye drops brand name", "dorzolamide eye drops brands" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }